STAT· @statnews · X·2026-11-12 22:11· 5 天前AI 评分38AI 导读Alnylam高度依赖其心脏药物Amvuttra实现增长——而销售已在放缓。https://trib.al/UikfsSp另有 1 家信源报道正文Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing. https://trib.al/UikfsSp来源:STAT · x.com#企业/市场#心血管#小分子查看事件全部后续